You searched for: taper phase (Engelska - Maltesiska)

phase
fażi

phase i
fażi i

fourth phase
ir-raba' fażi

delayed phase§§
fażi mdewma§§

accelerated phase phase
fażi aċċellerata (n = 157)ċ

corticosteroid taper was permitted after week 8.
it- tnaqqis tal- corticosteroid ftit ftit sakemm jitwaqqaf totalment, kien permess wara

corticosteroid taper was permitted after week 8. i
it- tnaqqis tal- corticosteroid ftit ftit sakemm jitwaqqaf totalment, kien permess wara ġimgħa 8.

dose reduction/ taper or discontinuation should be considered.
tnaqqis / tnaqqis gradwali jew waqfien tad- doża għandhom jiġu kkunsidrati.

upon improvement, nivolumab may be resumed after corticosteroid taper.
malli jidher titjib, nivolumab għandu jitkompla wara tnaqqis gradwali tal-kortikosterojdi.

upon improvement, nivolumab monotherapy may be resumed after corticosteroid taper.
meta jkun hemm titjib, il-monoterapija ta’ nivolumab tista’ terġa’ titkompla wara li d-doża tal- kortikosterojd titnaqqas gradwalment.

taper shall be expressed in centimetres per metre to one decimal place.
it-tirqieq lejn it-trud għandu jiġi espress f'ċentimeti għal kull metru sa figura deċimali waħda.

upon improvement, nivolumab may be resumed after corticosteroid taper, if needed.
meta jkun hemm titjib, nivolumab jista’ jer ġa’ jinbeda wara li d-doża tal-kortikosterojd tiġi mnaqqsa gradwalment, jekk ikun hemm bżonn.

therefore it is recommended to taper treatment (see section 4.2).
għalhekk hu rakkomandat li t - trattament jitwaqqaf ftit ftit (ara sezzjoni 4. 2).

patients subsequently underwent a mandatory taper schedule, with complete corticosteroid discontinuation by week 19.
pazjenti sussegwentement għaddew minn skeda obbligatorja li d-doża tiġi mnaqqsa ftit ftit, bi twaqqif komplut tal-kortikosterojdi sa Ġimgħa 19.

once rash or pruritus is controlled, initiation of corticosteroid taper should be based on clinical judgment.
Ġaladarba r-raxx jew il-ħakk jiġu kkontrollati, il-bidu tat-twaqqif gradwali tal-kortikosterojde għandu jiġi bbażat fuq il-ġudizzju kliniku.

once diarrhoea and other symptoms are controlled, the initiation of corticosteroid taper should be based on clinical judgment.
Ġaladarba d-dijarea u sintomi l-oħrajn jiġu kkontrollati, il-bidu ta’ tnaqqis gradwali tal-kortikosterojde għandu jiġi bbażat fuq il-ġudizzju kliniku.

in addition, patients could taper off concomitant itp medicinal products and receive rescue treatments as dictated by local standard of care.
flimkien ma’ dan, il-pazjenti setgħu jnaqqsu għal xejn għal xejn il-prodotti mediċinali għal itp li kienu qed jieħdu b’mod konkomitanti u jieħdu kuri ta’ salvataġġ kif ordnat mill-istandard lokali ta’ kura.

the study consisted of two parts with two independent primary endpoints (successful steroid taper and time to flare).
l-istudju kien jikkonsisti f’żewġ partijiet b’żewġ endpoints primarji indipendenti (tnaqqis bil-mod il-mod bl-isterojdi li rnexxa u żmien biex jerġa’ jkun hemm tħeġġiġ).

continuation of pembrolizumab may be considered, after corticosteroid taper, if needed (see section 4.2).
it-tkomplija ta’ pembrolizumab tista’ titqies wara li l-kortikosterojdi jkunu tnaqqasu bil-ftit il-ftit għal xejn, jekk ikun meħtieġ. (ara sezzjoni 4.2).

cpa 32.99.54: candles, tapers and the like
cpa 32.99.54: xemgħat, kandiletti u simili